Trial intelligence / Profile preview

Local anaesthesia before intramuscular magnesium sulphate injection to reduce pain

PACTR202201521544765Phase 1Completed

Sponsor
University of Botswana
Start
Apr 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of lidocaine and magnesium sulfate in preeclampsia and eclampsia (2 arms), sponsored by University of Botswana. Primary endpoint: Perceived pain after injection. Started Apr 2022; status: completed.

02

Drugs

lidocainemagnesium sulfate
03

Conditions

preeclampsiaeclampsia

Beyond the preview

Go deeper on PACTR202201521544765.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202201521544765.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call